SCHEMBL10353605

SCHEMBL10353605

CC(c1ccccc1)c1cccc2nc(S)[nH]c12

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ALPL P05186 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9306833 0.82 DAO (0.38) TSHRKDM4EPOLB
SCHEMBL11687448 0.80 KMT2A (0.38) TSHRHTTKDM4EKMT2A
SCHEMBL28412208 0.73 PSMD14 (0.33) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL9306736 0.70 CA12 (0.40) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL110725 0.70 ALDH1A1 (0.41) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL9306192 0.69 MAP4K4 (0.41) NPC1HTTRAB9ASMN1; SMN2KDM4E
SCHEMBL1524362 0.68 ALDH1A1 (0.40) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL4658430 0.68 TYR (0.54) TYRTSHRKDM4EMAPTKMT2A
SCHEMBL28485369 0.67 PARP1 (0.41) TSHRNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4156669 0.66 TYR (0.48) TYRTSHRHTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0190817-B1 DOPAMINE-BETA-HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1990-09-05 — — EP disclosed
US-4857540-A 1-SUBSTITUTED-2-MERCAPTO-(OR AMINOMETHYL-)BENZAMIDAZOLE COMPOUNDS SMITHKLINE BECKMAN CORPORATION (US) 1989-08-15 — — US disclosed
US-4728741-A DOPAMINE BETA-HYDROXYLASE INHIBITOR SMITHKLINE BECKMAN CORPORATION (US) 1988-03-01 — — US disclosed
EP-0190817-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1986-08-13 — — EP disclosed
Send feedback